Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11801
PUT
Corsair Gaming
CRSR
$1.28B
| $99K | ﹤0.01% |
+10,500
| New | +$84.7K |
|
11802
CALL
BeyondSpring
BYSI
$28.4M
| $98.9K | ﹤0.01% |
+42,100
| New | +$77.8K |
|
|
FLYY
11803
DELISTED
Spirit Aviation Holdings, Inc.
FLYY
| $98.6K | ﹤0.01% |
+19,757
| New | +$118K |
|
|
PFO
11804
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$118M
| $98.5K | ﹤0.01% |
+10,654
| New | +$95.1K |
|
11805
CALL
Inovio Pharmaceuticals
INO
$134M
| $98.5K | ﹤0.01% |
+48,300
| New | +$92.6K |
|
|
FTF
11806
Franklin Limited Duration Income Trust
FTF
$234M
| $98.4K | ﹤0.01% |
15,326
-11,811
| -44% | -$74.7K |
|
|
MTR
11807
Mesa Royalty Trust
MTR
$4.83M
| $98.2K | ﹤0.01% |
17,959
-4,376
| -20% | -$23.5K |
|
|
CMDB
11808
Costamare Bulkers Holdings
CMDB
$483M
| $98.2K | ﹤0.01% |
+11,321
| New | +$113K |
|
11809
OptimumBank Holdings
OPHC
$117M
| $97.9K | ﹤0.01% |
21,891
+3,604
| +20% | +$15.5K |
|
11810
PUT
Skye Bioscience
SKYE
$8.94M
| $97.8K | ﹤0.01% |
2,925
+1,262
| +76% | +$20.9K |
|
|
MSD
11811
Morgan Stanley Emerging Markets Debt Fund
MSD
$147M
| $97.6K | ﹤0.01% |
12,624
+1,152
| +10% | +$8.79K |
|
11812
Empire Petroleum
EP
$137M
| $97.2K | ﹤0.01% |
18,415
-3,822
| -17% | -$18.9K |
|
11813
Smart Sand
SND
$205M
| $97.2K | ﹤0.01% |
48,353
-12,269
| -20% | -$24.8K |
|
11814
Lucid Diagnostics
LUCD
$185M
| $97.1K | ﹤0.01% |
84,442
-106,013
| -56% | -$137K |
|
11815
Dynagas LNG Partners
DLNG
$138M
| $97.1K | ﹤0.01% |
+27,580
| New | +$99.1K |
|
11816
AirSculpt Technologies
AIRS
$196M
| $96.8K | ﹤0.01% |
20,035
+4,152
| +26% | +$14.1K |
|
11817
Veritone
VERI
$80.5M
| $96.7K | ﹤0.01% |
76,759
+30,051
| +64% | +$54.6K |
|
11818
PUT
Lifecore Biomedical
LFCR
$176M
| $96.6K | ﹤0.01% |
+11,900
| New | +$80.2K |
|
11819
Bridgeline Digital
BLIN
$12.3M
| $96.4K | ﹤0.01% |
69,386
+51,588
| +290% | +$84K |
|
11820
PUT
Vor Biopharma
VOR
$1.4B
| $96.4K | ﹤0.01% |
+2,975
| New | +$26.3K |
|
|
PLL
11821
PUT
DELISTED
Piedmont Lithium
PLL
| $96K | ﹤0.01% |
16,500
-55,000
| -77% | -$359K |
|
|
EU
11822
PUT
enCore Energy
EU
$266M
| $95.8K | ﹤0.01% |
33,500
+5,600
| +20% | +$10.1K |
|
|
IMMP
11823
Immutep
IMMP
$56M
| $95.6K | ﹤0.01% |
58,310
+10,853
| +23% | +$18.9K |
|
11824
CALL
RPC Inc
RES
$1.36B
| $95.5K | ﹤0.01% |
20,200
-9,600
| -32% | -$46.2K |
|
|
YARW
11825
Yarrow Bioscience
YARW
$106M
| $95.4K | ﹤0.01% |
1,156
+1
| +0.1% | +$65 |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.